$1.44
-0.0344-2.33%
Last update: Nov 12, 12:22 PM
Inovio Pharmaceuticals Inc
INONASDAQ
Inovio Pharmaceuticals fell 26.0% from $1.96 to $1.45, behind the S&P 500's +11.2%. Its worst day was Jul 30 (−36.9%), and its low came Oct 30 at $0.60.
Nov 12, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Inovio Pharmaceuticals closed at its highest level of the year, 32.7% above where the year started.
+12.1% · S&P 500 −1.1%
EPS of $-0.26 beat the $-0.35 estimate on $0.00 revenue (est. $20,000.00).
Story events cover the past 12 months · Times ET
−1.2% · S&P 500 −0.6%
EPS of $-0.28 beat the $-0.32 estimate on $0.00 revenue (est. $250,000.00).
+1.5% · S&P 500 +0.8%
EPS of $-0.07 beat the $-0.25 estimate on $0.00 revenue (est. $400,000.00).
+16.9% · S&P 500 +0.7%
Inovio Pharmaceuticals closed at its lowest level of the year, 69.3% below where the year started.
−21.9% · S&P 500 −1.8%
Where it ended: a close of $1.45 on Nov 10, 2026. Up next: Q4 2026 earnings on Mar 11, 2027 (EPS est. $-0.20, revenue est. $400,000.00).
Nothing in the past 12 months.
All INO dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for INO and SPY from Benzinga historical bars. Not investment advice.
